Motor cortex hyperexcitability to transcranial magnetic stimulation in Alzheimer's disease

被引:203
|
作者
Di Lazzaro, V
Oliviero, A
Pilato, F
Saturno, E
Dileone, M
Marra, C
Daniele, A
Ghirlanda, S
Gainotti, G
Tonali, PA
机构
[1] Univ Sacred Heart, Dipartimento Neurol, I-00168 Rome, Italy
[2] Stockholm Univ, Grp Interdisciplinary Cultural Studies, S-10691 Stockholm, Sweden
来源
关键词
D O I
10.1136/jnnp.2003.018127
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: Recent transcranial magnetic stimulation (TMS) studies demonstrate that motor cortex excitability is increased in Alzheimer's disease (AD) and that intracortical inhibitory phenomena are impaired. The aim of the present study was to determine whether hyperexcitability is due to the impairment of intracortical inhibitory circuits or to an independent abnormality of excitatory circuits. Methods: We assessed the excitability of the motor cortex with TMS in 28 patients with AD using several TMS paradigms and compared the data of cortical excitability ( evaluated by measuring resting motor threshold) with the amount of motor cortex disinhibition as evaluated using the test for motor cortex cholinergic inhibition ( short latency afferent inhibition) and GABAergic inhibition ( short latency intracortical inhibition). The data in AD patients were also compared with that from 12 age matched healthy individuals. Results: The mean resting motor threshold was significantly lower in AD patients than in controls. The amount of short latency afferent inhibition was significantly smaller in AD patients than in normal controls. There was also a tendency for AD patients to have less pronounced short latency intracortical inhibition than controls, but this difference was not significant. There was no correlation between resting motor threshold and measures of either short latency afferent or intracortical inhibition (r = 0.19 and 0.18 respectively, NS). In 14 AD patients the electrophysiological study was repeated after a single oral dose of the cholinesterase inhibitor rivastigmine. Resting motor threshold was not significantly modified by the administration of rivastigmine. In contrast, short latency afferent inhibition from the median nerve was significantly increased by the administration of rivastigmine. Conclusions: The change in threshold did not seem to correlate with dysfunction of inhibitory intracortical cholinergic and GABAergic circuits, nor with the central cholinergic activity. We propose that the hyperexcitability of the motor cortex is caused by an abnormality of intracortical excitatory circuits.
引用
收藏
页码:555 / 559
页数:5
相关论文
共 50 条
  • [21] Improvement of motor performance and modulation of cortical excitability by repetitive transcranial magnetic stimulation of the motor cortex in Parkinson's disease
    Lefaucheur, JP
    Drouot, X
    Von Raison, F
    Ménard-Lefaucheur, I
    Cesaro, P
    Nguyen, JP
    CLINICAL NEUROPHYSIOLOGY, 2004, 115 (11) : 2530 - 2541
  • [22] Impairment of motor cortex plasticity in Parkinson's disease, as revealed by theta-burst-transcranial magnetic stimulation and transcranial random noise stimulation
    Stephanie, Caspar
    Nitsche, Michael A.
    PARKINSONISM & RELATED DISORDERS, 2011, 17 (04) : 297 - 298
  • [23] Primary motor cortex hyperexcitability in Fabry's disease
    Ortu, Enzo
    Fancellu, Laura
    Sau, GianFranco
    Falchi, Paolo
    Traccis, Sebastiano
    Pes, Giovanni Mario
    Ganau, Antonello
    Sechi, GianPietro
    CLINICAL NEUROPHYSIOLOGY, 2013, 124 (07) : 1381 - 1389
  • [24] TRANSCRANIAL MOTOR CORTEX STIMULATION
    CRACCO, RQ
    ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY, 1986, 64 (04): : P67 - P67
  • [25] Transcranial magnetic stimulation in migraine with aura: further evidence of occipital cortex hyperexcitability.
    Aguggia, M
    Zibetti, M
    Febbraro, A
    Mutani, R
    CEPHALALGIA, 1999, 19 (04) : 465 - 465
  • [26] Effects of transcranial magnetic stimulation on neurobiological changes in Alzheimer's disease
    Bashir, Shahid
    Uzair, Mohammad
    Abualait, Turki
    Arshad, Muhammad
    Khallaf, Roaa A.
    Niaz, Asim
    Thani, Ziyad
    Yoo, Woo-Kyoung
    Tunez, Isaac
    Demirtas-Tatlidede, Asli
    Meo, Sultan Ayoub
    MOLECULAR MEDICINE REPORTS, 2022, 25 (04)
  • [27] Role of repetitive transcranial magnetic stimulation in management of alzheimer's disease
    Nachane, Hrishikesh B.
    Kedare, Jahnavi S.
    ANNALS OF INDIAN PSYCHIATRY, 2020, 4 (02)
  • [28] Effect of donepezil on transcranial magnetic stimulation parameters in Alzheimer's disease
    Hwang, Yun Tae
    Hammond, Paul
    Rocchi, Lorenzo
    Rawji, Vishal
    Hardy, Chris
    Warren, Jason
    Ridha, Basil
    Rothwell, John
    Rossor, Martin
    NEUROLOGY, 2017, 88
  • [29] Transcranial magnetic stimulation of deep brain regions in Alzheimer's disease
    Vakhapova, V.
    Korczyn, A. D.
    Zangen, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 : 364 - 364
  • [30] An overview of repetitive transcranial magnetic stimulation (rTMS) in Alzheimer's disease
    Alcala Lozano, Ruth
    Morelos Santana, Erik Daniel
    Osorio Rojas, Orely
    Gonzalez Olvera, Jorge Julio
    SALUD MENTAL, 2017, 40 (04) : 171 - 178